Also, in patients without MS, glycemic values were constant: 98.3 ± 14.0 mg/dL for methotrexate, 93.0 ± 18.2 mg/dL for anti-TNF-a and 88.8 ± 2.1 mg/dL for anti-IL-23. This evidence concerns the gene TNF and myeloid sarcoma.